These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 79765)

  • 1. Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci?
    Nikoskelainen J; Leino A; Lähtönen E; Kalliomäki JL; Toivanen A
    Lancet; 1978 Aug; 2(8086):403-5. PubMed ID: 79765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.
    Mäkelä PH; Peltola H
    Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal vaccines and disease due to other serogroups.
    Craven DE; Frasch CE; Robbins JB
    Lancet; 1978 Oct; 2(8096):939-40. PubMed ID: 81948
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogenity of serotypes of Neisseria meningitidis that cause endemic disease.
    Broud DD; Griffiss JM; Baker CJ
    J Infect Dis; 1979 Oct; 140(4):465-70. PubMed ID: 117060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of group-A meningococcal vaccine in army recruits in Finland.
    Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
    Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of meningococcal disease by group C polysaccharide vaccine.
    Artenstein MS; Gold R; Zimmerly JG; Wyle FA; Schneider H; Harkins C
    N Engl J Med; 1970 Feb; 282(8):417-20. PubMed ID: 4983754
    [No Abstract]   [Full Text] [Related]  

  • 9. Meningococcal disease in Africa.
    Hart CA; Cuevas LE
    Ann Trop Med Parasitol; 1997 Oct; 91(7):777-85. PubMed ID: 9625934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal group Y pneumonia in an adolescent female.
    Hersh JH; Gold R; Lepow ML
    Pediatrics; 1979 Aug; 64(2):222-4. PubMed ID: 112573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).
    Tryfinopoulou K; Kesanopoulos K; Xirogianni A; Marmaras N; Papandreou A; Papaevangelou V; Tsolia M; Jasir A; Tzanakaki G
    PLoS One; 2016; 11(12):e0167404. PubMed ID: 27907129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a group Y meningococcus from a patient with pneumonia.
    Hanson MF; Lawson A
    J Infect; 1985 Jan; 10(1):76-7. PubMed ID: 3920328
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia.
    Vienne P; Ducos-Galand M; Guiyoule A; Pires R; Giorgini D; Taha MK; Alonso JM
    Clin Infect Dis; 2003 Dec; 37(12):1639-42. PubMed ID: 14689345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.
    Chiou CS; Liao JC; Liao TL; Li CC; Chou CY; Chang HL; Yao SM; Lee YS
    BMC Infect Dis; 2006 Feb; 6():25. PubMed ID: 16478548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?
    Germinario C; Tafuri S; Napoli C; Montagna MT; Balducci MT; Fortunato F; Martinelli D; Prato R
    Hum Vaccin; 2010 Dec; 6(12):1025-7. PubMed ID: 21150271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of Neisseria meningitidis strains isolated from carriers in Cuba during 20 years].
    Martínez Motas I; Sierra González G; Núñez Gutiérrez N; Izquierdo Pérez L; Climent Ruíz Y; Mirabal Sosa M
    Rev Cubana Med Trop; 2006; 58(2):124-33. PubMed ID: 23427430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological and laboratory criteria in the assessment of meningococcus carrier state].
    Demina AA; Pokrovskiĭ VI; Kuz'menko SV; Deviatkina NP; Larina LI
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):79-85. PubMed ID: 64094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal carriage and vaccination in army recruits in Italy.
    Di Martino M; Calì G; Astorre P; Usai GC; Ferrari R; Stroffolini T
    Boll Ist Sieroter Milan; 1990; 69(1):357-9. PubMed ID: 2129323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France.
    Deghmane AE; Parent du Chatelet I; Szatanik M; Hong E; Ruckly C; Giorgini D; Lévy-Bruhl D; Alonso JM; Taha MK
    J Infect Dis; 2010 Jul; 202(2):247-50. PubMed ID: 20515410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.